The Michael J. Fox Foundation Announces Five Academic Centers Chosen for 2018-2020 Edmond J. Safra Fellowship in Movement Disorders

Thursday, April 13, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, April 13, 2017 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF), in collaboration

with longtime supporter and partner The Edmond J. Safra Foundation, has chosen five academic centers in the United States and Canada to host the third class of The Edmond J. Safra Fellowship
in Movement Disorders.

The centers selected for the 2018-2020 Edmond J. Safra Fellowship in Movement Disorders class are:

  • University of Alabama at Birmingham
  • Columbia University Medical Center in New York
  • Massachusetts General Hospital | Harvard Medical School in Boston
  • University of Michigan
  • Toronto Western Hospital in Ontario, Canada

Launched in 2014, The Edmond J. Safra Fellowship in Movement Disorders aims to bridge the gap in funding to train movement disorder specialists — neurologists who have expertise in diagnosing and managing Parkinson's disease. The program is specifically designed to grow the global base of clinician-researcher movement disorder specialists.

"By working with distinguished academic institutions to increase the number of movement disorder specialists, we can ensure people with Parkinson's have access to personalized care from experts at the forefront of research," said Mrs. Lily Safra, chairwoman of The Edmond J. Safra Foundation. "This program will ultimately benefit people with Parkinson's, who will receive remarkable care and have research designed with their interests in mind."

"We are thrilled to again be partnering with The Edmond J. Safra Foundation on this important initiative," said Todd Sherer, PhD, CEO of The Michael J. Fox Foundation. "This program continues to meet a critical need for specialists who can provide individualized patient care and lead research toward disease understanding and therapies to meet patients' needs." 

An advisory committee ranked applicants on several criteria, including the quality of clinical education and the research environment, in order to select the top centers. Each institution will now identify a fellow who will begin two years of training in July 2018.

Patients Informing the Research that Impacts ThemMovement disorder specialist clinician-researchers serve as a link between patients and the research necessary to gain deeper understandings of disease and develop new and better therapies. Regular patient interactions provide these specialists with unique insights into the patient experience and perspective that can directly inform their research projects. The Edmond J. Safra Fellowship in Movement Disorders is helping train experts who can form partnerships with their patients to advance research.

Ongoing Commitment to Parkinson's Research and CareLate banker and philanthropist Edmond J. Safra's namesake Foundation has long made Parkinson's disease care and research top priorities. Mrs. Safra, chairwoman of the Edmond J. Safra Foundation, has been an MJFF Board member since 2001.

In addition to generous gifts to centers and programs providing direct care to people with Parkinson's disease, Lily Safra and her Foundation have driven vital scientific investigation into new treatments. The fellowship is the latest among many partnerships between the Edmond J. Safra Foundation and MJFF, including the Edmond J. Safra Core Programs for PD Research, one of MJFF's central grantmaking avenues to support high-impact Parkinson's research projects. 

Applications for 2019-2021 Class Opening SoonThe 2019 Edmond J. Safra Fellowship application will soon be open to academic centers. Please check back on our website for more information and to apply.

About The Michael J. Fox Foundation for Parkinson's ResearchAs the world's largest nonprofit funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $700 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world.

For more information, visit us on the Web, Facebook, Twitter, LinkedIn and Pinterest.

About the Edmond J. Safra Philanthropic FoundationEdmond J. Safra, one of the 20th century's most accomplished bankers and a devoted philanthropist, established a major philanthropic foundation to ensure that individuals and organizations would continue to receive his assistance and encouragement for many years to come. Under the chairmanship of his beloved wife Lily, the Edmond J. Safra Philanthropic Foundation draws continuing inspiration from its founder's life and values, and supports hundreds of organizations in more than 40 countries around the world. Its work encompasses four areas: Education; Science and Medicine; Religion; and Humanitarian Assistance, Culture and Social Welfare. The Foundation has provided significant funding for Parkinson's disease research and patient care at dozens of hospitals and institutes in places as varied as Natal (Brazil), Toronto, New York, Grenoble, Paris, London and Jerusalem.

For more information, visit


To view the original version on PR Newswire, visit:

SOURCE The Michael J. Fox Foundation for Parkinson's Research


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store